DrugNov 12, 2014
Sun Pharma Global Venlafaxine Hydrochloride Extended-Release Tablets, 37.5 mg, 30-count recall — FDA D-0236-2015
Failed Dissolution Specifications; 12 month stability time point
Class IIFDA: TerminatedSun Pharma Global Inc.
10,690drug recall records
953FDA Class I records
8firms with 5+ records
Aidapak Services, LLC537 records
Database records
Records — page 332
10,690 detailed records are currently available in this category.
DrugNov 12, 2014
Oregon Compounding Centers, Inc. dba Creative ALPROSTADIL, 10 mcg/mL, injectable, 1.7 mL recall — FDA D-0173-2015
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential…
Class IIFDA: TerminatedOregon Compounding Centers, Inc. dba Creative Compounds
DrugNov 12, 2014
Oregon Compounding Centers, Inc. dba Creative METHYCOBALAMIN, preservative free, 20mg/mL recall — FDA D-0204-2015
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential…
Class IIFDA: TerminatedOregon Compounding Centers, Inc. dba Creative Compounds
DrugNov 12, 2014
Oregon Compounding Centers, Inc. dba Creative TESTOSTERONE CYPIONATE recall — FDA D-0223-2015
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential…
Class IIFDA: TerminatedOregon Compounding Centers, Inc. dba Creative Compounds
DrugNov 12, 2014
Oregon Compounding Centers, Inc. dba Creative PAPAVERINE HCL/PHENTOLAMINE MES/PROSTAGLANDIN recall — FDA D-0213-2015
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential…
Class IIFDA: TerminatedOregon Compounding Centers, Inc. dba Creative Compounds
DrugNov 12, 2014
Oregon Compounding Centers, Inc. dba Creative GLUTATHIONE with preservative, 100mg/mL recall — FDA D-0195-2015
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential…
Class IIFDA: TerminatedOregon Compounding Centers, Inc. dba Creative Compounds
DrugNov 12, 2014
Oregon Compounding Centers, Inc. dba Creative GLUTATHIONE, 100 mg/mL, injectable, 100 mL recall — FDA D-0196-2015
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential…
Class IIFDA: TerminatedOregon Compounding Centers, Inc. dba Creative Compounds
DrugNov 12, 2014
Physicians Total Care CEPHALEXIN MONOHYDRATE CAPSULES,USP, 500 mg, 20-count bottle recall — FDA D-0237-2015
CGMP deviations: Products were manufactured with active pharmaceutical ingredients that were not manufactured with good manufacturing practices.
Class IIFDA: TerminatedPhysicians Total Care, Inc.
DrugNov 12, 2014
Oregon Compounding Centers, Inc. dba Creative PAPAVERINE HCL/PHENTOLAMINE/PROSTAGLANDIN recall — FDA D-0214-2015
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential…
Class IIFDA: TerminatedOregon Compounding Centers, Inc. dba Creative Compounds
DrugNov 12, 2014
Apotex Candesartan Cilexetil Tablets, 4 mg, 30-count bottle recall — FDA D-0241-2015
Failed Impurities/Degradation Specifications: Out of specification (OOS) results were observed for CAD-II, CAD-V and Total Impurities.
Class IIIFDA: TerminatedApotex Inc.
DrugNov 12, 2014
Oregon Compounding Centers, Inc. dba Creative PAPAVERINE HCL, with preservative, 30 mg/mL recall — FDA D-0211-2015
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential…
Class IIFDA: TerminatedOregon Compounding Centers, Inc. dba Creative Compounds
DrugNov 12, 2014
Oregon Compounding Centers, Inc. dba Creative GANCICLOVIR -preservative free, 2mg/0.1mL recall — FDA D-0190-2015
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential…
Class IIFDA: TerminatedOregon Compounding Centers, Inc. dba Creative Compounds
DrugNov 12, 2014
Oregon Compounding Centers, Inc. dba Creative BEVACIZUMAB/DEXAMETHASONE, 1.25/0.5 mL recall — FDA D-0178-2015
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential…
Class IIFDA: TerminatedOregon Compounding Centers, Inc. dba Creative Compounds
DrugNov 12, 2014
Nanophase Technologies Z-COTE HP 1 TRANSPARENT ZINC OXIDE, Zinc Oxide (and) recall — FDA D-0238-2015
cGMP Deviation; The incorrect amount of a raw material was added during the manufacture of two lots of Z-COTE HP 1.
Class IIIFDA: TerminatedNanophase Technologies Corporation
DrugNov 12, 2014
Oregon Compounding Centers, Inc. dba Creative TOBRAMYCIN, 480mg/1000 mL, solution for recall — FDA D-0225-2015
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential…
Class IIFDA: TerminatedOregon Compounding Centers, Inc. dba Creative Compounds
DrugNov 12, 2014
Oregon Compounding Centers, Inc. dba Creative PAPAVERINE/PHENTOLAMINE/PROSTAGLANDIN recall — FDA D-0217-2015
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential…
Class IIFDA: TerminatedOregon Compounding Centers, Inc. dba Creative Compounds
DrugNov 12, 2014
Oregon Compounding Centers, Inc. dba Creative HYDROXOCOBALAMIN-preservative free (B12) recall — FDA D-0198-2015
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential…
Class IIFDA: TerminatedOregon Compounding Centers, Inc. dba Creative Compounds
DrugNov 12, 2014
Oregon Compounding Centers, Inc. dba Creative VITAMIN B COMPLEX (PRES) injectable, 100mg, 10 recall — FDA D-0228-2015
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential…
Class IIFDA: TerminatedOregon Compounding Centers, Inc. dba Creative Compounds
DrugNov 12, 2014
Oregon Compounding Centers, Inc. dba Creative PYRIDOXINE HCL, with preservative, 100 mg/mL recall — FDA D-0221-2015
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential…
Class IIFDA: TerminatedOregon Compounding Centers, Inc. dba Creative Compounds
DrugNov 12, 2014
Apotex Candesartan Cilexetil Tablets, 32 mg, a) 30-count bottle (NDC 60505-3621-3) b) recall — FDA D-0244-2015
Failed Impurities/Degradation Specifications: Out of specification (OOS) results were observed for CAD-II, CAD-V and Total Impurities.
Class IIIFDA: TerminatedApotex Inc.
DrugNov 12, 2014
Oregon Compounding Centers, Inc. dba Creative MITOMYCIN, 0.3mg/mL, injectable, 1 mL glass recall — FDA D-0207-2015
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential…
Class IIFDA: TerminatedOregon Compounding Centers, Inc. dba Creative Compounds
DrugNov 12, 2014
Oregon Compounding Centers, Inc. dba Creative PAPAVERINE/PHENTOLAMINE/ALPROSTADIL recall — FDA D-0215-2015
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential…
Class IIFDA: TerminatedOregon Compounding Centers, Inc. dba Creative Compounds
DrugNov 12, 2014
Oregon Compounding Centers, Inc. dba Creative ALPROSTADIL/LIDOCAINE HCL, 20mcg/5mg/mL, 1.25 recall — FDA D-0174-2015
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential…
Class IIFDA: TerminatedOregon Compounding Centers, Inc. dba Creative Compounds
DrugNov 12, 2014
Apotex Candesartan Cilexetil Tablets, 16 mg, a) 30-count bottle (NDC 60505-3620-3) b) recall — FDA D-0243-2015
Failed Impurities/Degradation Specifications: Out of specification (OOS) results were observed for CAD-II, CAD-V and Total Impurities.
Class IIIFDA: TerminatedApotex Inc.
How to use this drug recall index
A drug recall record can include the reason for recall, firm, status, distribution pattern, quantity and FDA classification. This site does not provide medical advice; it organizes public recall information and links users back to official sources.
Recall Lookup USA keeps the last complete source record available when an official data service is temporarily unavailable. When a source provides only a few fields, we show only those known facts rather than padding the page with generic text.
What the database can and cannot tell you
This database is designed for discovery and reference. It can help you locate a relevant recall record, identify the recalling firm or NHTSA campaign, compare dates and classifications, and follow the official source. It is not a substitute for a VIN-specific NHTSA check, a manufacturer notice, medical advice or instructions issued by the recalling company.